Prévisions

Aucune donnée d'analyste n'est disponible pour cette entreprise.

Actualités Accéder au fil d'actualités

Innoscripta share falls after Q2 update due to software migration

Innoscripta reported H1 2026 revenue growth of 43% to EUR 63m and an EBIT increase of 49% to EUR 36.4m, but confirmed its full-year guidance of EUR 140m revenue and EUR 80m EBIT. The stock fell about 9% after it said a software migration delayed filings and shifted parts of revenue into later quarters. Management expects the deferred volume to be recovered in H2 and is advancing expansion in France, the USA and the UK, but does not expect any material revenues there in 2026. The stock now trades at a P/E of 20.3 and a market capitalization of USD 961m. » Plus sur de.investing.com
Hohenester increases stake in innoscripta SE by purchasing 78,900 shares

Hohenester Beteiligungs-UG (haftungsbeschränkt) acquired a total of 78,900 innoscripta SE bearer shares at EUR 70.00 each on 02.03.2026; the transaction was officially reported on 03.03.2026. On 02.02.2026 Hohenester had already increased its holdings by 10,000 shares at EUR 91.37 each. In FSE trading the innoscripta share reacted with price gains, and the company is shown with a market value of EUR 740.00 million and a free float of 10,000,000 shares. » Plus sur finanzen.net
innoscripta publishes forecast for 2026: revenue ≥ €140 million, EBIT ≥ €80 million

innoscripta expects for the 2026 fiscal year, due to current business developments and strong demand, consolidated revenue of at least €140 million and EBIT of at least €80 million. The forecast is based on the current order situation, the scalability of the business model and a stable regulatory framework. » Plus sur finanzen.net